cor 143
Pill imprint cor 143 has been identified as Benztropine mesylate 0.5 mg.
Benztropine is used in the treatment of parkinson's disease; extrapyramidal reaction and belongs to the drug class anticholinergic antiparkinson agents. FDA has not classified the drug for risk during pregnancy.
Benztropine 0.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Benztropine mesylate Images
- Imprint:
-
cor 143
- Strength:
- 0.5 mg
- Color:
- White
- Size:
- 6.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- magnesium stearate
microcrystalline cellulose
povidone
corn starch
- Drug Class:
- Anticholinergic antiparkinson agents
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Rising Pharmaceuticals, Inc.
- National Drug Code (NDC):
- 64980-0111
| NDC Code | Manufacturer / Repackager |
|---|---|
| 00904-1055 | Major Pharmaceuticals |
| 64720-0143 | Core Pharmaceuticals Inc |
Note: Inactive ingredients may vary.
Advertisement
More Benztropine Mesylate resources
- Benztropine (Wolters Kluwer)
- Benztropine Tablets (Wolters Kluwer)
- benztropine (Cerner Multum)
- benztropine (Micromedex) - Includes Dosage Information
- benztropine Injection (Micromedex) - Includes Dosage Information
- Benztropine Mesylate (AHFS DI)
- Benztropine (FDA)
- Benztropine Injection (FDA)
- Benztropine Mesylate (Wolters Kluwer)
Search Again
